ALTRIA GROUP INC

Explore why Altria Group’s resilient tobacco brand delivers strong returns – a 57.9% 3‑year gain, solid P/E, and defensive dividend strategy amid industry decline.

Altria Group’s shares climb amid FDA’s foreign‑tobacco curbs, showing robust cash flow, steady dividends and resilience in a volatile market.

Altria’s dividend boost masks a shrinking cigarette core; investors face high yields but growing risk as ETFs pull back and diversification stalls.

Altria Group Inc’s profits rise while cigarette sales drop—investors weigh a costly smoke‑free shift against a solid 6% dividend and mixed market sentiment.

Altria’s 7.5% dividend rise keeps it a top pick for yield‑seeking investors, even as cigarette sales wane and regulation tightens—learn why the stock stays attractive.

Altria’s Q3 earnings show higher EPS but weaker sales, leading to a sharp share dip and UBS downgrades while the company lifts 2025 EPS guidance and boosts a $2bn buy‑back.

Altria Group Inc. will host a webcast on October 16, 2025, to present its third-quarter and nine-month earnings, providing insight into the company’s financial performance, guidance, and strategic initiatives.

Altria Group Inc. is undergoing a routine board transition with the retirement of George Muñoz, but its dividend policy and financial fundamentals remain unchanged, making it an attractive option for income-seeking investors.

Altria Group Inc. has reported strong Q2 earnings, exceeding expectations with a non-GAAP EPS of $1.44 and revenue of $6.1 billion.

Altria Group Inc. is navigating a week of significant financial developments, including a legal investigation, earnings concerns, and a credit rating upgrade, which will impact investor sentiment and the company’s future trajectory.